John Bayne serves as the Senior Director, Mergers & Acquisitions at The Oncology Institute. He brings more than nine years of healthcare M&A experience to the role. Prior to joining The Oncology Institute, he was the Senior Director of M&A at Quest Diagnostics where he focused on leveraging their lab assets into non-lab services growth: telehealth, extended care, home health, care coordination, population health and wellness. John also oversaw Quest’s VC Fund which focused on diagnostics technologies; healthcare data/analytics and population health related innovations.
Prior to his role at Quest, John worked in the M&A group at DaVita, where he worked on both dialysis and vascular access center acquisitions as well as value-based primary care clinics within the HealthCare Partners business (now part of OptumCare). Prior to DaVita, Mr. Bayne spent the first six years of his career in private equity investing and investment banking.
A resident of Tampa, Florida, he holds an undergraduate degree in finance from Trinity College Dublin in Ireland.